Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

GP KFPs / SAQsmens-health

GP KFPs / SAQs · mens-health

Erectile dysfunction — KFP-style written assessment

KFP-style staged scenarios on erectile dysfunction: the cardiovascular-lens first consultation, PDE5 inhibitor counselling with trial numbers and contraindications, testosterone in the non-responder, second-line escalation with injections and vacuum devices, and psychosexual therapy for psychogenic disease.

30 marks45 min4 min readVerification in progress

Target exams

RACGP KFPRACGP AKTMRCGP AKT
On this page
Study tools

Target exams

RACGP KFPRACGP AKTMRCGP AKT
Prompt
ED: a symptom that talks about arteries — assessing honestly, prescribing safely, escalating deliberately

KFP 1 (10 marks)

A 49-year-old solicitor attends after his partner insisted. Six months of gradual ED; morning erections still present most days but intercourse fails. Smokes 15/day, BMI 31, no regular doctor. His father had a bypass at 58.[6] [10]

  1. Outline your assessment, including why this presentation demands more than an ED prescription. (4) [6] [10]
  2. His bloods return: total cholesterol 6.8 mmol/L, HbA1c 5.9%, BP 148/92. How do these findings integrate? (3) [10] [1]
  3. He wants 'the blue tablet' immediately. What lifestyle prescriptions accompany it? (3) [8] [15]

Model answers

  1. Take the sexual history properly (onset, morning erections — preserved here, situational pattern), score IIEF-5, review medications and alcohol, screen depression, then assess cardiovascular risk formally. ED is a vascular warning sign: incident ED carried HR 1.25 (CI 1.02-1.53) for subsequent cardiovascular events, and prevalent or incident ED together HR 1.45 (CI 1.25-1.69); meta-analysis gives RR 1.62 for myocardial infarction, highest at younger ages — he is exactly that man. His father's premature bypass strengthens the case. [6] [10]
  2. The cluster (dyslipidaemia, borderline glycaemia, hypertension, obesity, smoking) is the same risk-factor bundle driving both his ED and future coronary events; MMAS showed impotence correlating directly with heart disease, hypertension and diabetes independent of age. Manage it as early vascular disease: formal absolute-risk calculation, lipid modification, BP treatment, smoking cessation — not just symptomatic therapy. [10] [1]
  3. Lifestyle change is evidence-based ED treatment, not an add-on: six randomised trials showed lifestyle interventions plus CV-risk pharmacotherapy improved IIEF-5 by weighted mean 2.66 points (CI 1.86-3.47). Smoking cessation specifically raised total IIEF within six months across age subgroups. Frame both as treatments for erections AND arteries, prescribed alongside sildenafil rather than instead of it. [8] [15]
General Practice Pro

Continue reading

You have read the opening of this kfps / saq. The complete unit — every section and its primary-source references — is part of the General Practice fellowship library.

Sign in to continueSee pricing
References13ShowHide
  1. [1]Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. The Journal of urology, 1994.PMID 8254833
  2. [2]Rosen RC, Riley A, Wagner G et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology, 1997.PMID 9187685
  3. [6]Thompson IM, Tangen CM, Goodman PJ et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA, 2005.PMID 16414947
  4. [10]Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circulation. Cardiovascular quality and outcomes, 2013.PMID 23300267
  5. [8]Gupta BP, Murad MH, Clifton MM et al. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Archives of internal medicine, 2011.PMID 21911624
  6. [15]Sahin MO, Sen V, Gunduz G et al. Effect of smoking cessation on sexual functions in men aged 30 to 60 years. International braz j urol : official journal of the Brazilian Society of Urology, 2020.PMID 32374127
  7. [3]Goldstein I, Lue TF, Padma-Nathan H et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. The New England journal of medicine, 1998.PMID 9580646
  8. [11]Yang M, Ni X, Sontag A et al. Nonresponders, partial responders, and complete responders to PDE5 inhibitors therapy according to IIEF criteria: validation of an anchor-based treatment responder classification. The journal of sexual medicine, 2013.PMID 24125113
  9. [12]Corona G, Rastrelli G, Morgentaler A et al. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. European urology, 2017.PMID 28434676
  10. [14]Duncan C, Omran GJ, Teh J et al. Erectile dysfunction: a global review of intracavernosal injectables. World journal of urology, 2019.PMID 30895359
  11. [18]Zhang F, Luo Z, Xue Q et al. Efficacy of vacuum erectile device in refractory erectile dysfunction: a systematic review and meta-analysis. International journal of impotence research, 2026.PMID 40542251
  12. [17]Cocci A, Capogrosso P, Minhas S et al. Penile prosthesis implantation: a systematic review of intraoperative and postoperative complications. International journal of impotence research, 2026.PMID 40514408
  13. [7]Melnik T, Soares BG, Nasello AG The effectiveness of psychological interventions for the treatment of erectile dysfunction: systematic review and meta-analysis, including comparisons to sildenafil treatment, intracavernosal injection, and vacuum devices. The journal of sexual medicine, 2008.PMID 18564156
General Practice Pro

$29/ monthor $279 / year

The complete General Practice library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousBenign prostatic hyperplasia / LUTS — KFP-style written assessmentmens-healthNextPSA testing and prostate cancer — KFP-style written assessmentmens-health